Scheepers Paul T J, van Brederode Nelly E, Bos Peter M J, Nijhuis Nicole J, van de Weerdt Rik H J, van der Woude Irene, Eggens Martin L
Department for Health Evidence, Radboud university medical center, PO Box 9101, 6500 HB Nijmegen, The Netherlands.
National Institute of Public Health and the Environment, PO Box 1, 3720 BA Bilthoven, The Netherlands.
Toxicol Lett. 2014 Dec 15;231(3):295-305. doi: 10.1016/j.toxlet.2014.03.002. Epub 2014 Mar 13.
Biological monitoring in humans (HBM) is widely used in the field of occupational and environmental health. In the situation of an unexpected release of hazardous materials HBM may contribute to the medical support and treatment of exposed individuals from the general population or of emergency responders. Such exposure information may also be used to respond to individual concerns such as questions about a possible relationship between the chemicals released during the incident and health effects. In The Netherlands a guideline was prepared to support early decision-making about the possible use of HBM for exposure assessment during or as soon as possible following a chemical incident. The application of HBM in such an emergency setting is not much different from situations where HBM is normally used but there are some issues that need extra attention such as the choice of the biomarker, the biological media to be sampled, the time point at which biological samples should be collected, the ethics approval and technical implementation of the study protocol and the interpretation and communication of the study results. These issues addressed in the new guideline will support the use of HBM in the management of chemical disasters.
人体生物监测(HBM)在职业与环境卫生领域被广泛应用。在有害物质意外释放的情况下,人体生物监测有助于为普通人群中的暴露个体或应急响应人员提供医疗支持与治疗。此类暴露信息还可用于回应个人关切,比如事件期间释放的化学物质与健康影响之间可能存在的关系等问题。在荷兰,已制定了一项指南,以支持在化学事故期间或之后尽快就人体生物监测用于暴露评估的可能性做出早期决策。人体生物监测在这种紧急情况下的应用与正常使用人体生物监测的情况并无太大差异,但有一些问题需要格外关注,例如生物标志物的选择、要采集样本的生物介质、采集生物样本的时间点、研究方案的伦理批准和技术实施以及研究结果的解读与交流。新指南中涉及的这些问题将有助于在化学灾害管理中使用人体生物监测。